Evaluation of Some Trace Elements in Follicular Fluid in ICSI Cases and Their Effect on ICSI Outcomes

Launched by ASSIUT UNIVERSITY · Dec 5, 2024

Keywords

ClinConnect Summary

This clinical trial is examining the levels of certain trace elements found in the fluid surrounding eggs during a procedure called ICSI (Intracytoplasmic Sperm Injection) and how these levels might affect the success of the ICSI process. The goal is to understand if these trace elements play a role in helping women achieve pregnancy after this assisted reproductive technology.

To participate in this study, women need to be considered "good responders," meaning they have specific hormone levels indicating a healthy response to fertility treatments. Specifically, they should have an Anti-Müllerian Hormone (AMH) level greater than 0.8 ng/dl and at least four small fluid-filled sacs called antral follicles. If eligible, participants can expect to provide samples for analysis and may help researchers learn more about the factors that influence fertility outcomes. The trial is currently recruiting participants and is focused on helping women who are looking to improve their chances of conception through ICSI.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria:good responders according to NICE guidelines with AMH more than 0.8ng/dl and antral follicular count more than 4 Exclusion Criteria:Poor responders according to ESHRE guidelines as advanced maternal age poor ovarian response and according to NICE guidelines AMH less than 0.8ng/dl